Characteristics of prior steroid use predicts duration of steroid therapy in inflammatory bowel disease (IBD)

被引：0
|
作者：
Lewis, JD [1 ]
Lichtenstein, GR [1 ]
Brensinger, C [1 ]
Bilker, WB [1 ]
Strom, BL [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1396
引用
收藏
页码：A269 / A269
页数：1
相关论文
共 50 条
  • [1] Tacrolimus in steroid refractory inflammatory bowel disease (IBD)
    Fellermann, K
    Ludwig, D
    Stahl, M
    DavidWalek, T
    Hriesek, C
    Stange, EF
    GASTROENTEROLOGY, 1997, 112 (04) : A971 - A971
  • [2] Treatment of older inflammatory bowel disease patients; steroid use and escalation to steroid sparing therapy
    Asscher, V.
    Provoost, N.
    Meijer, L.
    van der Meulen-de Jong, A.
    van Deudekom, F.
    Mooijaart, S.
    Maljaars, J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S395 - S395
  • [3] Steroid use in inflammatory bowel disease patients on biological therapy in Montenegro
    Smolovic, B.
    Lukic, M.
    Sekulic, O.
    Muhovic, D.
    Milosevic, V.
    Vukcevic, B.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S419 - S420
  • [4] Therapy of Steroid-Resistant Inflammatory Bowel Disease
    Manz, Michael
    Vavricka, Stephan R.
    Wanner, Roger
    Lakatos, Peter L.
    Rogler, Gerhard
    Frei, Pascal
    Safroneeva, Ekaterina
    Schoepfer, Alain M.
    DIGESTION, 2012, 86 : 11 - 15
  • [5] Age Disparities in the Use of Steroid-sparing Therapy for Inflammatory Bowel Disease
    Govani, Shail M.
    Wiitala, Wyndy L.
    Stidham, Ryan W.
    Saini, Sameer D.
    Hou, Jason K.
    Feagins, Linda A.
    Sussman, Jeremy B.
    Higgins, Peter D. R.
    Waljee, Akbar K.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (08) : 1923 - 1928
  • [6] Steroid dependency and steroid resistance in inflammatory bowel disease
    García-Paredes, J
    Gomollón, F
    Santamaría, DMC
    Abreu, L
    Vera, M
    Fazio, VW
    Sandborn, WS
    DRUGS OF TODAY, 2001, 37 : 17 - 18
  • [7] Treatment of steroid refractory inflammatory bowel disease (IBD) with mycophenolate mofetil (MMF)
    Florin, THJ
    Roberts, RK
    Watson, MR
    Radford-Smith, GL
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1998, 28 (03): : 344 - 345
  • [8] Cyclosporine in patients with inflammatory bowel disease refractory to steroid therapy
    Dejaco, C
    Gasche, C
    Reinisch, W
    Moser, G
    Novacek, G
    Tillinger, V
    Vogelsang, H
    Gangl, A
    WIENER KLINISCHE WOCHENSCHRIFT, 1998, 110 (16) : 579 - 584
  • [9] Treating beyond symptoms in inflammatory bowel disease (IBD): the Kent IBD Nurse Experience with the Steroid assessment tool
    Scott, G.
    Lewis, W.
    Roads, N.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S224 - S224
  • [10] Therapy of steroid resistant inflammatory bowel disease. Immunomodulators or biologicals?
    Manz, M.
    Schoepfer, A. M.
    COLOPROCTOLOGY, 2014, 36 (06) : 433 - 438
12345